Evotec (EVO)
(Delayed Data from NSDQ)
$3.71 USD
0.00 (0.00%)
Updated Aug 30, 2024 11:51 AM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Evotec AG [EVO]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Evotec AG
Industry: Medical - Drugs
Soft 1Q Performance Not a Big Surprise, Expect Recovery In 2H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
A Needed "Reset" Though Uncertainty Persists; Lower PT to $11; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Optimized Entry and Exit Levels for EVO 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Evotec AG
Industry: Medical - Drugs
Evotec Emerges Stronger Following Cyberattack; PT Up to $14; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec Reaps Rewards from Collaboration with Bristol Myers Squibb
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec''s Advances in Drug Discovery, Development and Manufacturing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Company: Evotec AG
Industry: Medical - Drugs
Stepping on the Accelerator of Drug Development; Initiate at Buy With $12 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|